New Jersey – 3rd September, 2020. Algorics a data focused biometrics service provider, today announced the release of MetaVate solution designed for Pharma, Biotech and CRO organizations to drive significant efficiencies around clinical data standardization and transformation process. This solution will be available as part of their standard offering for all customers. The MetaVate solution allows organization to standardize and automate programming libraries, data specifications, metadata repositories and submission packages needed for regulatory approval. Through this automation MetaVate reduces the resources required and decreases the time taken, thus speeding up the overall trial submission process. Algorics’ CEO Nithiya Ananthakrishnan said “As the impact of COVID-19 continues to grow the need to rapidly complete delayed and cancelled trials, while ensuring COVID-19 trials themselves proceed in a timely manner, is paramount. We look forward to rolling out MetaVate for all our customers on their current and future clinical trials”.
Algorics today also announced the release of their new website with focus on its biometrics services and MetaVate solution. Reflecting on the changing priorities of the industry over the last 6 months the website provides dedicated COVID-19 content including links to published articles, recordings of webinars and an opportunity to register for their next webinar on the impact of missing data due to COVID-19 that runs on September 17th. Nithiya added “2020 has been a challenging year for the entire industry but we are grateful that we can join the battle against the pandemic by offering our expertise on how to address the issues that COVID-19 is causing.”
Algorics is a data focused biometrics services provider with expertise in biostatistics, statistical programming and data standards. For more information about Algorics visit: https://algorics.com
Algorics is a proud partner of https://covidcollaborators.org/